These miRNAs target particular mRNAs that affect the protein expression involved in BC development, such as the transmembrane glycoprotein cluster of differentiation 44 (CD44), estrogen receptor (ER), progesterone receptor (PR), and receptor tyrosine-protein kinase erbB-2 (HER-2) [96]. The gene discussed is CD44; the disease is breast cancer.